We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Croda International plc (CRDA) ORD GBP0.10609756

Sell:2,781.00p Buy:2,783.00p 0 Change: 112.00p (4.19%)
FTSE 100:0.29%
Market closed |  Prices as at close on 16 October 2025 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:2,781.00p
Buy:2,783.00p
Change: 112.00p (4.19%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 16 October 2025 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:2,781.00p
Buy:2,783.00p
Change: 112.00p (4.19%)
Market closed |  Prices as at close on 16 October 2025 Prices delayed by at least 15 minutes | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

HL comment (16 October 2025)

No recommendation - No news or research item is a personal recommendation to deal. All investments can fall as well as rise in value so you could get back less than you invest.

Croda’s third quarter sales grew 6.5% to £425mn (5.9% expected), when ignoring currency movements.

Growth was led by the Consumer Care business which saw a rebound in Beauty Actives and strong double-digit gains in Flavours & Fragrances.

In Life Sciences, a continued recovery in Crop Protection more than offset weakness in sales to Pharmaceutical customers.

All regions contributed positively to sales growth, except Asia, where US trade tariffs weighed on performance.

Full-year pre-tax profit guidance of £265-295mn remains unchanged.

The shares were up 3.9% in early trading.

Our view

HL view to follow.

Croda key facts

  • Forward price/earnings ratio (next 12 months): 16.9

  • Ten year average forward price/earnings ratio: 25.2

  • Prospective dividend yield (next 12 months): 4.3%

  • Ten year average prospective dividend yield: 2.2%

All ratios are sourced from LSEG Datastream, based on previous day’s closing values. Please remember yields are variable and not a reliable indicator of future income. Keep in mind key figures shouldn’t be looked at on their own – it’s important to understand the big picture.

This article is original Hargreaves Lansdown content, published by Hargreaves Lansdown. It was correct as at the date of publication, and our views may have changed since then. Unless otherwise stated estimates, including prospective yields, are a consensus of analyst forecasts provided by LSEG. These estimates are not a reliable indicator of future performance. Yields are variable and not guaranteed. Investments rise and fall in value so investors could make a loss.

This article is not advice or a recommendation to buy, sell or hold any investment. No view is given on the present or future value or price of any investment, and investors should form their own view on any proposed investment.


Previous Croda International plc updates





Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.